Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota
1 other identifier
observational
27
1 country
4
Brief Summary
D.fragilis is an intestinal protozoon that feeds by phagocytosis of intestinal bacteria. The study aim to determine if the carriage of the intestinal parasite D.fragilis is associated to changes of gut microbiota in subjects presenting with or without intestinal symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2016
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2015
CompletedFirst Posted
Study publicly available on registry
August 27, 2015
CompletedStudy Start
First participant enrolled
February 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2019
CompletedMarch 12, 2025
March 1, 2025
3.1 years
August 24, 2015
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
16SrRNA copy numbers
Within the 2 days following inclusion
Study Arms (2)
Symptomatic subjects
Subjects with intestinal symptoms
Asymptomatic subjects
Subjects without intestinal symptoms
Interventions
Eligibility Criteria
Symptomatic subjects will be recruited during their visit to hospital for intestinal symptoms. Asymptomatic subjects will be recruited in the general population.
You may qualify if:
- male/female aged at least of 18 years
- subject with abdominal pain, diarrhea, bloating
- no other known intestinal disease
- male/female aged at least of 18 years
- no known intestinal disease
You may not qualify if:
- chronic intestinal diseases such as IBD, IBS …
- intake of antibiotic or probiotic within the 2 last months
- subject unable to understand information for a free consent to the study
- subject in safeguarding justice or guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Laboratoire de Parasitologie et de Mycologie Médicale du Plateau Technique de Microbiologie des Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Médecine interne, maladies tropicales et infectieuses Hôpital Civil
Strasbourg, 67091, France
Service de Médecine Interne - Diabète et Maladies métaboliques Hôpital Civil
Strasbourg, 67091, France
Service d'hépato gastro-entérologie et assistance nutritive Hôpital Hautepierre
Strasbourg, 67098, France
Biospecimen
Stool
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CANDOLFI Ermanno, MD
Hôpitaux Universitaires de Strasbourg
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2015
First Posted
August 27, 2015
Study Start
February 16, 2016
Primary Completion
March 29, 2019
Study Completion
March 29, 2019
Last Updated
March 12, 2025
Record last verified: 2025-03